All articles by GlobalData Healthcare

GlobalData Healthcare

RSV infections pose threat to millions of elderly adults in nursing homes this fall

RSV infections can be threatening both for young infants and older adults in nursing homes and the risk is higher in shared spaces so caution should be taken.

Mouth cancer cases are rising sharply in the UK

Diagnosed incident cases of mouth cancer in the UK are projected to increase at an annual growth rate of 1.20% from 2022 to 2030.

Protective benefits of dietary flavonoids against colorectal cancer

Recent studies have found an inverse relationship between the risk of colorectal cancer and high dietary flavonoid intake.

Regenerative medicine clinical trials continue to rise

There are currently more than 1,500 regenerative medicine clinical trials in GlobalData’s Pharma Intelligence Centre.

Alpha-1-antitrypsin deficiency: the most prevalent rare disease

The number of clinical trials for A1ATD drugs has steadily declined since 2016 and not entered double digits in recent decades.

CRISPR therapy NTLA-2001 demonstrates durable responses in rare heart disease

There have been durable responses from the CRISPR therapy NTLA-2001, which have caused positivity for its healthcare prospects and its potential for further investment.

Fungal infections increased significantly over the Covid-19 pandemic

A number of fungal infection outbreaks occurred during the pandemic.

Sotatercept- the breakthrough PAH has been waiting for?

Originally developed by Acceleron Pharma, sotatercept is the only drug to have achieved breakthrough therapy designation in the US for PAH.

US data shows surge in alcohol consumption and related deaths

The alarming numbers behind alcohol-associated mortality certainly present a policy challenge

NHS aims to eliminate healthcare inequalities for people with autism

More attention is to be paid to driving healthcare improvements for the health of people with autism, which are likely to make them more comfortable.